Headquartered in Boston, Massachusetts, MPM BioImpact combines biotech venture capital expertise with company-building initiatives to power novel medical breakthroughs and transform patient outcomes.
Subscribe to see MPM BioImpact’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
MPM BioImpact is a biotechnology & venture capital company headquartered in United States. Xcout tracks 12 named people at MPM BioImpact, including Ying Huang (Chief Executive Office of K2 Therapeutics and Strategic Advisor, APAC).
6 more named people on record for MPM BioImpact, with roles, board committees and tenure — see the full roster →
A few of MPM BioImpact's closest competitors — see the full list of competitors and alternatives →
Population Health Partners builds, funds, and grows companies focused on extending human healthspan and addressing prevalent chronic diseases. The firm originates, incubates, and invests in biopharma and healthcare companies designed to prevent major diseases at population scale.
EGB Ventures is a physician-led venture formation family office that creates, finances, and develops biotechnology companies focused on clinically validated therapeutic opportunities and significant unmet medical needs. The firm identifies breakthrough science, structures new ventures, recruits management teams, and guides strategic development from pre-clinical stages onward.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about MPM BioImpact? Suggest a correction
Post the link and the card appears automatically — each network fetches the image itself.